SBI Securities Co. Ltd. bought a new stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 31,369 shares of the health services provider's stock, valued at approximately $285,000.
A number of other institutional investors and hedge funds have also bought and sold shares of TDOC. Point72 Asset Management L.P. raised its stake in Teladoc Health by 57.8% in the third quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider's stock valued at $76,803,000 after purchasing an additional 3,063,172 shares in the last quarter. Maple Rock Capital Partners Inc. bought a new position in Teladoc Health during the third quarter valued at approximately $11,291,000. Invenomic Capital Management LP grew its position in Teladoc Health by 155.2% during the third quarter. Invenomic Capital Management LP now owns 1,474,337 shares of the health services provider's stock valued at $13,534,000 after acquiring an additional 896,552 shares during the last quarter. Nisa Investment Advisors LLC grew its position in Teladoc Health by 20,936.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider's stock valued at $3,874,000 after acquiring an additional 424,180 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. grew its position in Teladoc Health by 141.9% during the third quarter. Robeco Institutional Asset Management B.V. now owns 575,055 shares of the health services provider's stock valued at $5,279,000 after acquiring an additional 337,305 shares during the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.
Teladoc Health Trading Down 2.5 %
TDOC stock traded down $0.23 on Friday, reaching $9.16. The company's stock had a trading volume of 6,617,418 shares, compared to its average volume of 8,427,815. The business has a fifty day simple moving average of $10.62 and a two-hundred day simple moving average of $9.65. Teladoc Health, Inc. has a 12-month low of $6.76 and a 12-month high of $15.95. The firm has a market cap of $1.59 billion, a PE ratio of -1.59 and a beta of 1.27. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73.
Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million during the quarter, compared to analysts' expectations of $639.44 million. As a group, research analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current year.
Wall Street Analyst Weigh In
A number of research analysts have commented on TDOC shares. Bank of America increased their price target on shares of Teladoc Health from $11.50 to $13.50 and gave the company a "neutral" rating in a research report on Wednesday, February 12th. Royal Bank of Canada increased their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Oppenheimer reduced their price target on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research report on Friday, January 24th. The Goldman Sachs Group reduced their price target on shares of Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday, March 3rd. Finally, Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a report on Thursday, February 27th. Eleven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, Teladoc Health currently has a consensus rating of "Hold" and a consensus target price of $11.26.
Read Our Latest Report on Teladoc Health
About Teladoc Health
(
Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Further Reading
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
